United States· US:70377-103_2681dc2f-b544-e29d-90af-ce64675fdd8b
AMINOCAPROIC ACID
A aminocaproic acid product containing aminocaproic acid, registered in United States by Biocon Pharma Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AMINOCAPROIC ACID
- Manufacturer
- Biocon Pharma Inc.
- Country
- United States (US)
- ATC code
- B02AA01
- ATC class
- Aminocaproic acid
- Defined daily dose
- 16 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11703771031130 TABLET in 1 BOTTLE (70377-103-11)
- ndc1170377-103-11
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
97 interactions on record for aminocaproic acid.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aminocaproic acid · interactions on record
97 records
- 5 severe
- 8 moderate
- 1 minor
- 83 info
Most severe, free to view
- Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03severe
- TretinoinL01XF01severe
- CarfilzomibL01XG02severe
- TretinoinL01XX14severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B02AA01
Aminocaproic acid, as other registers publish it.
- United StatesAminocaproic acidNovadoz Pharmaceuticals LLC
- United StatesAminocaproic acidBPI LABS LLC
- United StatesAminocaproic acidAmneal Pharmaceuticals LLC
- United StatesAminocaproic acidNovadoz Pharmaceuticals LLC
- United StatesAminocaproic acidMajor Pharmaceuticals
- United StatesAminocaproic acidTruPharma LLC
- United StatesAminocaproic acidMajor Pharmaceuticals
- United StatesAminocaproic acidNovadoz Pharmaceuticals LLC
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Hungary · Acepramin
- Portugal · Epsicaprom, Epsicaprom 25
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d48b10c3-f312-4671-b3db-253e7a2aff38 GET /v1/drugs/d48b10c3-f312-4671-b3db-253e7a2aff38?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1000",
"substance": "AMINOCAPROIC ACID",
"productndc": "70377-103",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA213928",
"marketing_category": "ANDA"
}See everything about aminocaproic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.